| Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD B Watkins, M Qayed, C McCracken, B Bratrude, K Betz, Y Suessmuth, ... Journal of clinical oncology 39 (17), 1865, 2021 | 136 | 2021 |
| National Marrow Donor Program–sponsored multicenter, phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide BE Shaw, AM Jimenez-Jimenez, LJ Burns, BR Logan, F Khimani, ... Journal of clinical oncology 39 (18), 1971, 2021 | 109 | 2021 |
| Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission A Rashidi, M Hamadani, MJ Zhang, HL Wang, H Abdel-Azim, M Aljurf, ... Blood advances 3 (12), 1826-1836, 2019 | 107 | 2019 |
| National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IIa. The 2020 clinical implementation and … CL Kitko, J Pidala, HM Schoemans, A Lawitschka, ME Flowers, ... Transplantation and cellular therapy 27 (7), 545-557, 2021 | 90 | 2021 |
| Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and … Y Inamoto, N Valdés-Sanz, Y Ogawa, M Alves, L Berchicci, J Galvin, ... Bone marrow transplantation 54 (5), 662-673, 2019 | 89 | 2019 |
| Incidence, risk factors for and outcomes of transplant‐associated thrombotic microangiopathy N Epperla, A Li, B Logan, C Fretham, S Chhabra, M Aljurf, L Chee, ... British journal of haematology 189 (6), 1171-1181, 2020 | 76 | 2020 |
| Age no bar: a CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma PN Munshi, D Vesole, A Jurczyszyn, JM Zaucha, A St. Martin, O Davila, ... Cancer 126 (23), 5077-5087, 2020 | 55 | 2020 |
| Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia MJ Wieduwilt, L Metheny III, MJ Zhang, HL Wang, N Estrada-Merly, ... Blood advances 6 (1), 339-357, 2022 | 48 | 2022 |
| Incidence, risk factors, and outcomes of patients who develop mucosal barrier injury–laboratory confirmed bloodstream infections in the first 100 days after allogeneic … CE Dandoy, S Kim, M Chen, KW Ahn, MI Ardura, V Brown, S Chhabra, ... JAMA network open 3 (1), e1918668-e1918668, 2020 | 47 | 2020 |
| Association of reduced-intensity conditioning regimens with overall survival among patients with non-Hodgkin lymphoma undergoing allogeneic transplant N Ghosh, S Ahmed, KW Ahn, M Khanal, C Litovich, M Aljurf, VU Bacher, ... JAMA oncology 6 (7), 1011-1018, 2020 | 43 | 2020 |
| Relapse and disease-free survival in patients with myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation using older matched sibling donors vs … GSG Murthy, S Kim, ZH Hu, N Estrada-Merly, MB Abid, M Aljurf, U Bacher, ... JAMA oncology 8 (3), 404-411, 2022 | 42 | 2022 |
| Risk factors for graft-versus-host disease in haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide A Im, A Rashidi, T Wang, M Hemmer, ML MacMillan, J Pidala, M Jagasia, ... Biology of blood and marrow transplantation 26 (8), 1459-1468, 2020 | 42 | 2020 |
| Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia CJ Lee, S Kim, HR Tecca, S Bo-Subait, R Phelan, R Brazauskas, ... Blood advances 4 (6), 983-992, 2020 | 42 | 2020 |
| New monoclonal antibodies for the treatment of acute lymphoblastic leukemia N Farhadfar, MR Litzow Leukemia research 49, 13-21, 2016 | 42 | 2016 |
| Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma–type Richter syndrome AF Herrera, KW Ahn, C Litovich, Y Chen, A Assal, Q Bashir, RL Bayer, ... Blood advances 5 (18), 3528-3539, 2021 | 35 | 2021 |
| Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis NN Shah, KW Ahn, C Litovich, TS Fenske, S Ahmed, M Battiwalla, ... Blood advances 2 (8), 933-940, 2018 | 34 | 2018 |
| Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial AE DeZern, M Eapen, J Wu, JA Talano, M Solh, BJD Saldaña, C Karanes, ... The Lancet Haematology 9 (9), e660-e669, 2022 | 33 | 2022 |
| Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma … N Epperla, KW Ahn, C Litovich, S Ahmed, M Battiwalla, JB Cohen, P Dahi, ... Journal of Hematology & Oncology 12, 1-11, 2019 | 33 | 2019 |
| Real‐world experience of carfilzomib‐associated cardiovascular adverse events: SEER‐Medicare data set analysis R Bishnoi, Z Xie, C Shah, J Bian, HS Murthy, JR Wingard, N Farhadfar Cancer medicine 10 (1), 70-78, 2021 | 32 | 2021 |
| Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era B Dhakal, S Patel, S Girnius, L Bachegowda, R Fraser, O Davila, ... Leukemia 34 (12), 3338-3347, 2020 | 32 | 2020 |
